Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology, assessment and treatment of psoriatic dactylitis
Dennis McGonagle, Ai Lyn Tan, ‬‬‬‬Abdulla Watad, et al.
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 2, pp. 113-122
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
Yoshiya Tanaka, Yiming Luo, John J. O’Shea, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 3, pp. 133-145
Open Access | Times Cited: 334
The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study
Giovanni Damiani, Nicola Luigi Bragazzi, C. Karimkhani Aksut, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 223
Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia
Alen Zabotti, Dennis McGonagle, Ivan Giovannini, et al.
RMD Open (2019) Vol. 5, Iss. 2, pp. e001067-e001067
Open Access | Times Cited: 77
The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study
Mohammad Adawi, Giovanni Damiani, Nicola Luigi Bragazzi, et al.
Nutrients (2019) Vol. 11, Iss. 3, pp. 601-601
Open Access | Times Cited: 76
Interleukin-17 cytokines: Effectors and targets in psoriasis—A breakthrough in understanding and treatment
Immo Prinz, Inga Sandrock, Ulrich Mrowietz
The Journal of Experimental Medicine (2019) Vol. 217, Iss. 1
Open Access | Times Cited: 74
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Elsa Vieira‐Sousa, Pedro Augusto Alves, Ana Maria Rodrigues, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 4, pp. 490-498
Open Access | Times Cited: 54
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
Paolo Gisondi, Francesco Bellinato, Martina Maurelli, et al.
Psoriasis Targets and Therapy (2022) Vol. Volume 12, pp. 213-220
Open Access | Times Cited: 25
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy
Aurélie Najm, Carl S. Goodyear, Iain B. McInnes, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 3, pp. 153-165
Closed Access | Times Cited: 16
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets
Maria Sole Chimenti, Paola Triggianese, Erica De Martino, et al.
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 8, pp. 823-836
Closed Access | Times Cited: 35
Power Doppler enhancement of accessory pulleys confirming disease localization in psoriatic dactylitis
Ilaria Tinazzi, Dennis McGonagle, Pierluigi Macchioni, et al.
Lara D. Veeken (2019) Vol. 59, Iss. 8, pp. 2030-2034
Open Access | Times Cited: 33
Ultrasound Imaging in Psoriatic Arthritis: What Have We Learnt in the Last Five Years?
Sayam Dubash, Gabriele De Marco, Richard J. Wakefield, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 32
Novel and reliable DACTylitis glObal Sonographic (DACTOS) score in psoriatic arthritis
Alen Zabotti, Garifallia Sakellariou, Ilaria Tinazzi, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 8, pp. 1037-1043
Closed Access | Times Cited: 30
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study
Philip J. Mease, Dafna D. Gladman, Atul Deodhar, et al.
RMD Open (2020) Vol. 6, Iss. 2, pp. e001217-e001217
Open Access | Times Cited: 30
Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis
Sayam Dubash, Oras Alabas, Xabier Michelena, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 4, pp. 490-495
Open Access | Times Cited: 27
The ultrasonographic spectrum of toe dactylitis in psoriatic arthritis: a descriptive analysis
Garifallia Sakellariou, Nicolò Girolimetto, Ilaria Tinazzi, et al.
Clinical Rheumatology (2025)
Open Access
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis
Nicolò Girolimetto, Pierluigi Macchioni, Ilaria Tinazzi, et al.
Clinical Rheumatology (2019) Vol. 39, Iss. 4, pp. 1157-1165
Closed Access | Times Cited: 28
Psoriatic Dactylitis: Current Perspectives and New Insights in Ultrasonography and Magnetic Resonance Imaging
Nicolò Girolimetto, Ivan Giovannini, G. Crepaldi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2604-2604
Open Access | Times Cited: 21
Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
Chrysoula G. Gialouri, Gerasimos Evangelatos, G. Fragoulis
Mediterranean Journal of Rheumatology (2022) Vol. 33, Iss. Suppl 1, pp. 150-150
Open Access | Times Cited: 15
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA
Pascal Richette, Marijn Vis, Sarah Ohrndorf, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002934-e002934
Open Access | Times Cited: 9
BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management
Helena Marzo‐Ortega, Ai Lyn Tan, Dennis McGonagle, et al.
Rheumatology Advances in Practice (2020) Vol. 4, Iss. 2
Open Access | Times Cited: 20
Psoriatic arthritis in childhood: A commentary on the controversy
Matthew L. Stoll, Elizabeth Mellins
Clinical Immunology (2020) Vol. 214, pp. 108396-108396
Closed Access | Times Cited: 16
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study
Nicolò Girolimetto, Pierluigi Macchioni, Giorgia Citriniti, et al.
Clinical Rheumatology (2020) Vol. 39, Iss. 11, pp. 3383-3392
Closed Access | Times Cited: 12
Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies
Dennis McGonagle, Iain B. McInnes, Atul Deodhar, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 4, pp. 227-240
Open Access | Times Cited: 4
Machine learning identifies right index finger tenderness as key signal of DAS28-CRP based psoriatic arthritis activity
Samuel Rischke, Sorwe Mojtahed Poor, Robert Gurke, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis
Manami Kato, Kei Ikeda, Takahiro Sugiyama, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252116-e0252116
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top